Tidetron Bioworks
PrivateLast Round
Series A
Extension
Mar 14, 2022
Total Funding Raised
$100M
Company Overview
Tidetron Bioworks operates in Healthcare & Life Sciences and is based in Guangzhou. Its latest recorded funding round was a Series A Extension round in March 2022.
Tidetron Bioworks is a synthetic biology company that develops and operates a biomanufacturing platform for the mass production of sustainable materials for the biomedical, cosmetics, and food industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials, Clean Manufacturing, Fashion & Beauty
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tidetron Bioworks Comparables
Compare Tidetron Bioworks with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cataya Bio | 83% | |
| Bota Biosciences | 83% | |
| Chirial Biomaterial Co., Ltd. | 79% |
For institutional investors. Book with your work email.
Tidetron Bioworks Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Mar 14, 2022 | ||||
| Series A | May 1, 2021 | ||||
| Angel | May 1, 2021 |
For institutional investors. Book with your work email.
Tidetron Bioworks Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IDG Capital | Angel, Series A, Series A Extension |
| ZhenFund | Angel, Series A |
| Legend Capital | Series A Extension, Series A |
| Unity Ventures | Angel, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Monthly visitors increased 38% MoM.
- Mar 2, 2026
Monthly visitors grew 77% MoM.
For institutional investors. Book with your work email.
Tidetron Bioworks Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Tidetron Bioworks's valuation, stock price, and market status.
Is Tidetron Bioworks a public or private company?
Tidetron Bioworks is a private company.
What is the current stock price of Tidetron Bioworks?
Tidetron Bioworks is a private company, so its shares have no public market price. Caplight tracks Tidetron Bioworks's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Tidetron Bioworks worth (valuation)?
Valuation information for Tidetron Bioworks is not publicly available.
Can I buy Tidetron Bioworks stock?
Tidetron Bioworks shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Tidetron Bioworks's last funding round?
Tidetron Bioworks's most recent funding round was Series A Extension on March 14, 2022.
Who are the main investors in Tidetron Bioworks?
Key investors in Tidetron Bioworks include IDG Capital, Legend Capital.
Will Tidetron Bioworks IPO soon?
No public IPO plans have been announced for Tidetron Bioworks.
How can I track Tidetron Bioworks secondary market activity?
Caplight tracks bids, offers, and trades in Tidetron Bioworks's shares on secondary markets.